Vericel Quarterly Balance Sheet
NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vericel financial position
As of Jun 30, 2026, Vericel reported total assets of $502.9 million, up 15.4% from a year earlier against total liabilities of $132.8 million. Shareholders' equity stood at $370.0 million, or 73.6% of assets. The company held $125.4 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.04, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Vericel balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 125.36M | 109.30M | 100.09M | 100.40M | 80.53M | 73.49M | 74.52M | 53.68M | 50.29M | 62.94M | 69.09M | 60.47M |
| Short-Term Investments | 37.10M | 36.05M | 37.41M | 34.98M | 36.35M | 39.41M | 41.69M | 48.05M | 52.22M | 47.71M | 40.47M | 44.87M |
| Receivables | 75.71M | 72.38M | 84.63M | 60.43M | 64.29M | 52.90M | 61.38M | 48.48M | 48.00M | 49.93M | 58.36M | 39.73M |
| Inventory | 18.38M | 18.35M | 17.56M | 18.16M | 16.83M | 17.11M | 17.37M | 15.76M | 14.89M | 13.56M | 13.09M | 12.62M |
| Total Current Assets | 264.73M | 244.06M | 247.44M | 221.97M | 204.58M | 197.64M | 212.78M | 190.52M | 197.39M | 189.72M | 205.63M | 186.21M |
| Property, Plant & Equipment | 105.60M | 107.11M | 108.40M | 109.38M | 109.85M | 108.29M | 103.16M | 88.41M | 73.09M | 56.39M | 41.63M | 30.22M |
| Intangible Assets | 5.31M | 5.47M | 5.63M | 5.78M | 5.94M | 6.09M | 6.25M | 6.41M | 6.56M | 6.72M | 6.88M | 7.03M |
| Long-Term Investments | 64.97M | 65.28M | 61.40M | 49.66M | 47.40M | 43.34M | 39.88M | 32.90M | 26.12M | 29.43M | 25.28M | 20.23M |
| Total Assets | 502.87M | 485.63M | 487.97M | 453.27M | 435.61M | 424.59M | 432.72M | 390.40M | 376.84M | 356.66M | 353.66M | 318.13M |
| Accounts Payable | 20.61M | 19.01M | 15.83M | 15.34M | 12.86M | 16.75M | 23.85M | 20.88M | 25.22M | 19.43M | 22.35M | 15.05M |
| Total Current Liabilities | 52.53M | 47.16M | 49.15M | 45.58M | 41.13M | 39.45M | 50.29M | 41.35M | 43.86M | 36.47M | 45.75M | 35.95M |
| Total Liabilities | 132.82M | 129.40M | 133.33M | 131.42M | 128.80M | 129.10M | 140.75M | 132.93M | 133.86M | 122.77M | 127.70M | 113.75M |
| Shareholders' Equity | 370.04M | 356.23M | 354.64M | 321.86M | 306.81M | 295.49M | 291.97M | 257.47M | 242.98M | 233.90M | 225.95M | 204.38M |
| Retained Earnings | -380.39M | -382.60M | -376.30M | -399.54M | -404.61M | -404.06M | -392.81M | -412.62M | -411.72M | -407.04M | -403.18M | -416.17M |
| Net Cash (Debt) | 162.46M | 145.34M | 137.50M | 135.38M | 116.88M | 112.90M | 116.21M | 101.73M | 102.51M | 110.65M | 109.56M | 105.34M |
| Shares Outstanding | 51.17M | 51.01M | 50.62M | 50.55M | 50.44M | 50.25M | 49.63M | 49.27M | 48.86M | 48.49M | 47.83M | 47.68M |
This table shows 12 quarterly periods of Vericel's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow VCEL's reporting calendar. What is a balance sheet?